Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cardiocentro Ticino Foundation is a specialized university clinic for cardiovascular medicine located in Lugano, Switzerland. Integrated into the Ente Ospedaliero Cantonale (EOC) in 2021, the center combines high-level clinical care in cardiology and cardiac surgery with advanced translational research. A cornerstone of its research infrastructure is the Lugano Cell Factory, a GMP-certified facility dedicated to the production of advanced therapy medicinal products (ATMPs), including stem cell and exosome-based therapies. The foundation is a leader in regenerative medicine, participating in numerous international clinical trials focused on treating heart failure and myocardial infarction.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cardiocentro Ticino Foundation.